Advertisement

Topics

Human medicines European public assessment report (EPAR): Humira, adalimumab, Revision: 54, Authorised

12:00 EST 21 Feb 2017 | European Medicines Agency

This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Humira, adalimumab, Revision: 54, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Humira, adalimumab, Revision: 54, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement